Strategic Partnership with August Global Partners to transform cancer care with AI and Genomics
Gene Solutions has announced a strategic partnership with August Global Partners—an independent private equity fund spun off from EDBI, a Singapore state-owned fund—to leverage genomics and artificial intelligence (“AI”) in cancer care. At the signing ceremony in Singapore, Founder Dr. Nguyen Hoai Nghia unveiled an AI suite, developed by Gene Solutions through years of clinical research and expertise in DNA testing across reproductive health and oncology, that enhances precision medicine and targeted therapeutics. This technology will reduce gene sequencing costs while significantly improving test performance, making personalized solutions more accessible.
In 2024, Gene Solutions recorded a 15% year-on-year growth in revenue, mainly driven by both the increase in the Non-Invasive Prenatal Testing (NIPT) and oncology tests, driven by efforts to expand test variations with diverse price ranges and features.
Gene Solutions, founded by three Vietnamese scientists and doctors with solid experience in genetics, cancer biology, and biotechnology, is a leading genetic testing company that specializes in Non-Invasive Prenatal Testing (“NIPT”) for pregnant women and a pioneer in oncology with its early cancer detection technology, SPOT-MAS™. Gene Solutions currently has presence in Vietnam, Singapore, Indonesia, Thailand, and the Philippines.